MIRA · Forms 3, 4, 5
Insider trades at MIRA PHARMACEUTICALS, INC.
No open-market insider buys or sells at MIRA PHARMACEUTICALS, INC. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for MIRA PHARMACEUTICALS, INC. (MIRA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for MIRA PHARMACEUTICALS, INC. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Matthew Pratt Whalen | Director | Options or other derivatives | Form 4 | ||||
| Giudice Matthew Paul Del | Director | Options or other derivatives | Form 4 | ||||
| Edward Clouston MacPherson | Director | Options or other derivatives | Form 4 | ||||
| Denil Nanji Shekhat | Director | Options or other derivatives | Form 4 | ||||
| Andriy Mushak | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Erez Aminov | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Erez Aminov | CEO and Chairman | Option exercise | 234,595 | $1.16 | $272K | Form 5 | |
| Erez Aminov | CEO and Chairman | Option exercise | 379,000 | $0.84 | $318K | Form 5 | |
| Erez Aminov | CEO and Chairman | Sell | 613,595 | $2.11 | $1.3M | Form 5 | |
| MIRA PHARMACEUTICALS, INC. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Denil Nanji Shekhat | Director | Award | 22,378 | $1.35 | $30K | Form 4 | |
| Erez Aminov | Chief Executive Officer | Award | 2,685,456 | Form 4 | |||
| Erez Aminov | CEO and Chairman | Award | 62,500 | $1.45 | $91K | Form 5 | |
| Erez Aminov | CEO and Chairman | Award | 62,500 | $1.45 | $91K | Form 5 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.